Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bendetowicz

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 14, 2021
Frontotemporal dementia subtypes based on behavioral inhibition deficitsValérie Godefroy, Delphine Tanguy, Arabella Bouzigues, et al.
Movement Disorders Clinical Practice|April 20, 2026
Continuous Apomorphine Infusion in Multiple System Atrophy Real-World Insights From a French Nationwide Retrospective CohortSimon Lamy, Frederique Leh, Alexandra Foubert-Samier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2025
Stridor Is an Independent Risk Factor for Mortality and Disease Progression in Patients with Multiple System AtrophyPauline Dodet, Cecile Proust-Lima, Federico Sirna, et al.
Movement Disorders Clinical Practice|August 6, 2025
Development and Feasibility of a Mixed Virtual and in-Presence Therapeutic Education Program for Early Multiple System Atrophy PatientsMargherita Fabbri, Estelle Harroch, Eva Camgrand, et al.
NPJ Parkinson'S Disease|June 12, 2021
Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life studyBruna Meira, Bertrand Degos, Elise Corsetti, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Alzheimer'S Research & Therapy|May 11, 2023
Phenotype and imaging features associated with APP duplicationsLou Grangeon, Camille Charbonnier, Aline Zarea, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 14, 2021
Frontotemporal dementia subtypes based on behavioral inhibition deficitsValérie Godefroy, Delphine Tanguy, Arabella Bouzigues, et al.
Movement Disorders Clinical Practice|April 20, 2026
Continuous Apomorphine Infusion in Multiple System Atrophy Real-World Insights From a French Nationwide Retrospective CohortSimon Lamy, Frederique Leh, Alexandra Foubert-Samier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2025
Stridor Is an Independent Risk Factor for Mortality and Disease Progression in Patients with Multiple System AtrophyPauline Dodet, Cecile Proust-Lima, Federico Sirna, et al.
Movement Disorders Clinical Practice|August 6, 2025
Development and Feasibility of a Mixed Virtual and in-Presence Therapeutic Education Program for Early Multiple System Atrophy PatientsMargherita Fabbri, Estelle Harroch, Eva Camgrand, et al.
NPJ Parkinson'S Disease|June 12, 2021
Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life studyBruna Meira, Bertrand Degos, Elise Corsetti, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Alzheimer'S Research & Therapy|May 11, 2023
Phenotype and imaging features associated with APP duplicationsLou Grangeon, Camille Charbonnier, Aline Zarea, et al.
Pageof 3